Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
36%

OVERLAP
BY WEIGHT
14

# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
27%
ALSO IN HRTS
HRTS
42
HOLDINGS
33%
ALSO IN CANC
SECTOR DRIFT (CANC minus HRTS)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in HRTS
Overlap
ELI LILLY & CO 4.4% 10.6% 4.4%
ROCHE HOLDINGS LTD-SPONS ADR 4.1% 4.5% 4.1%
ASTRAZENECA PLC 3.5% 4.0% 3.5%
MERCK & CO. INC. 3.4% 4.1% 3.4%
NOVARTIS AG 4.1% 3.4% 3.4%
CANC Overweight Relative to HRTS
REVOLUTION MEDICINES, INC. 4.1%
COGENT BIOSCIENCES INC 3.8%
IMMUNOME, INC. 3.8%
CELCUITY INC. 3.7%
NUVALENT, INC. CLASS A 3.1%
LEGEND BIOTECH CORPORATION SPONSORED 3.0%
EXELIXIS INC 2.8%
CG ONCOLOGY, INC. 2.6%
ZAI LAB LTD. UNSPONSORED ADR 2.4%
GENMAB A/S SPONSORED ADR 2.4%
CANC Underweight Relative to HRTS
ELI LILLY & CO -6.2%
UNITEDHEALTH GROUP INC -5.5%
NOVO NORDISK A/S-B -5.4%
THERMO FISHER SCIENTIFIC INC -3.6%
VERTEX PHARMACEUTICALS INC -2.9%
ABBOTT LABORATORIES -2.6%
DANAHER CORP -2.4%
GILEAD SCIENCES INC -2.3%
CYTOKINETICS INC -2.1%
TEVA PHARMACEUTICAL-SP ADR -2.0%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY